NeoGenomics, Inc.
https://neogenomics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From NeoGenomics, Inc.
Orange County Entrepreneur Banks On Data-Based Approach To Detect, Treat Diseases
IV BioHoldings CEO Marty Keiser connects data, technology, capital and people to create start-ups focusing on liquid biopsy programs.
Big Money Spent On Liquid Biopsy Technology In 2021
Deal-making and financing activities are on the rise for liquid biopsy diagnostic products in 2021 despite questions remaining around whether the technology can unseat standard-of-care biomarker and imaging tests.
Big Money Spent On Liquid Biopsy Technology In 2021
Deal-making and financing activities are on the rise for liquid biopsy diagnostic products in 2021 despite questions remaining around whether the technology can unseat standard-of-care biomarker and imaging tests.
PerkinElmer To Buy UK-Based Immunodiagnostics For $155M
PerkinElmer will add chemiluminescence products in endocrinology, autoimmunity and diagnostics to its portfolio with the planned buyout of Immunodiagnostics.
Company Information
- Industry
- Biotechnology
- Contract Research Organization-CRO
-
Laboratory Testing Services
- Anatomical Pathology
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Other Names / Subsidiaries
-
- Clarient, Inc.
- Genoptix, Inc.
- Genoptix Medical Laboratory
- Inviata Ltd.
- NeoGenomics Laboratories
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice